|
| 38012333 | A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial. | Psychopharmacology (Berl) | 2024 |
| 36282988 | Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study. | Am J Drug Alcohol Abuse | 2023 |
| 37634240 | Before and During the First COVID-19 Surge: Work Conditions, Burnout, and Mental Health Among Resident Physicians in a Department of Psychiatry in the USA. | Acad Psychiatry | 2023 |
| 37096768 | Alcohol Use Among Treatment-Seeking Individuals With Opioid Use Disorder. | J Stud Alcohol Drugs | 2023 |
| 35133639 | Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. | Drugs | 2022 |
| 35754106 | Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial. | Addict Biol | 2022 |
| 36102596 | Ibudilast moderates the effect of mood on alcohol craving during stress exposure. | Exp Clin Psychopharmacol | 2022 |
| 34080890 | Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial. | Am J Psychiatry | 2021 |
| 34816185 | Psychological Distress Among Women Healthcare Workers: A Health System's Experience Developing Emotional Support Services During the COVID-19 Pandemic. | Front Glob Womens Health | 2021 |
| 34175784 | Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers. | Drug Alcohol Depend | 2021 |
| 34120149 | Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial. | Transl Psychiatry | 2021 |
| 32156222 | Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review. | J Psychoactive Drugs | 2020 |
| 32525378 | Implementing an emotional support and mental health response plan for healthcare workers during the COVID-19 pandemic. | Psychol Trauma | 2020 |
| 32399837 | Understanding the Experiences of First-Generation Medical Students: Implications for a Diverse Physician Workforce. | Acad Psychiatry | 2020 |
| 30418260 | Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder. | J Addict Med | 2019 |
| 30215195 | Implementing an Addiction Medicine Module-Based Educational Platform. | Acad Psychiatry | 2019 |
| 31160146 | Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descent. | Drug Alcohol Depend | 2019 |
| 30373394 | State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. | Am J Drug Alcohol Abuse | 2019 |
| 29265379 | Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial. | Alcohol Clin Exp Res | 2018 |
| 29802367 | Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm. | Neuropsychopharmacology | 2018 |
| 29752906 | Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures. | Am J Med | 2018 |
| 27861439 | Trends in Tramadol: Pharmacology, Metabolism, and Misuse. | Anesth Analg | 2017 |
| 28476267 | Chronic pain among patients with opioid use disorder: Results from electronic health records data. | J Subst Abuse Treat | 2017 |
| 28426439 | High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System. | J Addict Med | 2017 |
| 28492461 | Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review. | J Psychiatr Pract | 2017 |
| 28091532 | Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial. | Neuropsychopharmacology | 2017 |
| 29349344 | Adaptation and Evaluation of Military Resilience Skills Training for Pediatric Residents. | J Med Educ Curric Dev | 2017 |
| 27087145 | A Pilot Study of the Safety and Initial Efficacy of Ivermectin for the Treatment of Alcohol Use Disorder. | Alcohol Clin Exp Res | 2016 |
| 28076677 | A Call to Action: The Active Role Psychiatrists and the DEA Must Take to Decrease Harm from Psychotropic Drugs Acquired via the Internet. | J Clin Psychiatry | 2016 |
| 27554389 | A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients. | Am J Addict | 2016 |
| 24949564 | Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. | Am J Drug Alcohol Abuse | 2015 |
| 25801501 | The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study. | Neuropsychopharmacology | 2015 |
| 24733235 | Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. | Psychopharmacology (Berl) | 2014 |
| 23298651 | The effects of varenicline on stress-induced and cue-induced craving for cigarettes. | Drug Alcohol Depend | 2013 |
| 23916320 | Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports. | Drug Alcohol Depend | 2013 |
| 23616210 | Primary care management of opioid dependence: the addition of CBT gives no extra benefit compared to standard physician management alone. | Evid Based Ment Health | 2013 |
| 23240711 | Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. | Alcohol Clin Exp Res | 2013 |
| 21900886 | Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study. | Neuropsychopharmacology | 2012 |
| 22475985 | Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxone. | J Addict Med | 2012 |
| 22640762 | Managing co-occurring substance use and pain disorders. | Psychiatr Clin North Am | 2012 |
| 22105061 | Comparison of buprenorphine treatment for opioid dependence in 3 settings. | J Addict Med | 2012 |
| 21142706 | Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. | Am J Drug Alcohol Abuse | 2011 |
| 24474855 | Selective review and commentary on emerging pharmacotherapies for opioid addiction. | Subst Abuse Rehabil | 2011 |
| 21487653 | A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. | Psychopharmacology (Berl) | 2011 |
| 20201811 | Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics. | CNS Neurol Disord Drug Targets | 2010 |
| 20840201 | Withdrawal symptoms in abstinent methamphetamine-dependent subjects. | Addiction | 2010 |
| 20188495 | Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. | Drug Alcohol Depend | 2010 |
| 19637105 | Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients. | Am J Drug Alcohol Abuse | 2009 |
| 27186086 | Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence. | J Exp Pharmacol | 2009 |
| 17938635 | Changes in cerebral glucose metabolism during early abstinence from chronic methamphetamine abuse. | Mol Psychiatry | 2008 |